AzTrials
AzTrials

Peritoneal MalignancyPANONCT05305820

Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy

A study testing Exercise and Nutrition in people with Peritoneal Malignancy and Ovarian Cancer, run by Dublin City University at 3 sites in Ireland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

People who are diagnosed with cancer of the colon/rectum/appendix/ovaries that spreads into the lining of the tummy and some ovarian cancers or people with pseudomyxoma peritonei can often undergo intensive treatment including major surgery where chemotherapy is given whilst the person is having surgery - also known… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Exercise and Nutrition
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
3 sitesIreland
Study dates
1 Sep 2022to 1 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age ≥18 years,
  • multidisciplinary team referral for CRS-HIPEC for colorectal/appendix/ovarian peritoneal disease or pseudomyxoma peritonei (+/- completed neoadjuvant cancer treatment)
  • WHO performance status ≤2.

Who cannot join

  • inability to provide informed consent,
  • impaired cognitive function with a reduced ability to either understand advice /instructions from or communicate with the research team,
  • declined surgery,
  • surgery in less than 2 weeks
  • pregnancy or breastfeeding,
  • inability to participate in the exercise training (unable to perform the 6 Minute Walk Test)
  • absolute contraindications to exercise testing, veganism.

Trial locations and contacts

3 sites in 1 country.

Ireland3 sites
  • Dublin City University

    Dublin

  • Mater Misericordiae university hospital

    Dublin

  • Royal College of Surgeons , Ireland

    Dublin

Other trials in Ireland

About this study

Official title: The PANO Trial: Perioperative Exercise and Nutrition Optimisation Prehabilitation in Cancer Patients With Peritoneal Malignancy

People who are diagnosed with cancer of the colon/rectum/appendix/ovaries that spreads into the lining of the tummy and some ovarian cancers or people with pseudomyxoma peritonei can often undergo intensive treatment including major surgery where chemotherapy is given whilst the person is having surgery - also known by doctors as surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Fitness for this surgery can improve if people undertake a prehabilitation programme at the time they get their diagnosis. To date, little research has focused on how exercise and nutrition support before surgery can help these patients during recovery. The aim of this study is to explore the use of exercise and nutritional support pre-treatment to enhance physical and psychological outcomes for patients.

Read the detailed description

The comparator in this study will be standard oncological care. Control patients will receive the same care as standard without the addition of a formal exercise and nutrition support programme. The pre-treatment (prehabilitation) programme will commence following diagnosis and continue up to the point of surgery and recommence for six weeks following surgery when deemed clinically fit to participate. Assessments will occur at baseline, pre-surgery, post-surgery, and 6 weeks later and a follow up... Mixed methods will be employed with patients taking part in self-report assessments, physical assessments, and qualitative interviews. The primary aim of the study is to assess the feasibility of the intervention and cardiorespiratory fitness pre-surgery. The secondary aims include assessing the effect of the intervention on physical health, psychological wellbeing, health-related quality of life, self-efficacy, nutrition, and serology markers. Exploratory aims also include post-operative morbidity, health economics analysis and qualitative interview of patient experience.

Being tested
Exercise, Nutrition
Keywords
Peritoneal Malignancy
Medical subject headings
Ovarian Neoplasms, Rectal Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    Also called Tailored Exercise Prehabilitation Program

    Standard Exercise Program- Participants will be invited to take part in a structured home, supervised, or both, exercise program while undergoing treatment and for a six-week period when deemed fit post-surgery.

  • NutritionBehavioural

    Also called Nutritional Optimisation

    Participants will be screened for their nutritional health and tailored advice and education will be provided on an individualised basis. An online dietary recall tool will be used to track patients' dietary habits. This will occur from diagnosis until point of surgery and recommence for 6 weeks post-surgery once deemed physically fit.

Study groups in NCT05305820
Study groupRoleWhat they receive
InterventionExperimentalExercise: The exercise training program was designed to improve physical fitness prior to surgery and for a 6-week period after surgery once deemed fit. Nutrition: The nutritional arm consists of nutritional intervention tailored to the outcome of the nutritional screening.Participants will be asked to take part in a dietary food recall system called Foodbook24, and based on their dietary needs will be supported in nutritional optimisation.
Receives: Behavioral: Exercise; Behavioral: Nutrition
ControlNo interventionThis group will receive standard oncological care and will receive no formal education of exercise or nutritional intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of Adherence to the Intervention

    Prehabilitation fidelity in terms of the patient group adherence as measured by patient structured qualitative feedback and activity logs.

    Measured: 2-6 weeks pre surgery, 6 weeks post-surgery

  2. Feasibility of participant retention to the Intervention

    Prehabilitation fidelity in terms of the patient group retention as measured by patient screening and retention logs and monitoring of recruitment rates.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

  3. Feasibility of intervention effectiveness

    Prehabilitation fidelity in terms of intervention effectiveness as measured by qualitative patient feedback at two timepoints. Monitoring of patient activity logs. Engagement with online and in-person exercise and nutritional intervention resources.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

  4. Change in Cardiorespiratory Fitness

    Cardiorespiratory fitness using the 6-Minute Walk Test (6MWT) assessed at the pre-surgery time point. The 6MWT is performed with participants walking up and down a 20 m course marked by cones for 6 min under instruction to cover as much ground as possible. The number of laps completed is recorded. A standard set of instructions is used as per the European Respiratory Society guidelines. The 6MWT is a validated assessment of cardiorespiratory function in clinical populations.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

Secondary outcomes (14)
  1. Change in Strength - The Handgrip Test

    This is measured using a hand dynamometer. The test will be conducted in a standing position with the upper arm tight against the participant's trunk and the forearm at a right angle to the upper arm. If this is not possible the participant may sit in an upright chair or use their free hand to rest the dynamometer on a table to support the arm. The gripping handle will be set to a comfortable width to ensure the patient can rest the middle piece of the four fingers on the handle. The participant will be instructed to squeeze the handle with maximum force for a few seconds. The value on the scale will be recorded. The participant will complete two trials on each hand. The highest score will be accepted.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

  2. Change in Strength - The Stand to Sit Test

    Participants will sit on a chair (height 43-45 cm) with arms crossed on their, and legs flat on the floor, parallel to each other, and approximately shoulder width apart. Participants will stand up and sit down 10 times as quickly as possible. Participants must not bounce off the chair when moving from a seated position to standing position. They must fully extend their legs on each stand. The time taken to perform 10 repetitions will be timed using a stopwatch. Participants will perform two trials and the best trial will be recorded as their score.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

  3. Change in Activity - 3-day ActivPAL3 triaxial accelerometer

    Participants will be instructed to wear the device on the midpoint of the anterior aspect of the right thigh and attach using a film adhesive frame dressing. They will continue to wear this for three days continuously. They cannot wear the ActivPAL3 triaxial accelerometer during water activity periods.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

  4. Change in Psychological Stress

    NCCN Distress Thermometer: To detect distress (psychosocial stress) with all stages of cancer. This is measured using a visual analogue scale like a thermometer to indicate a range from 0 (not loaded) to 10 (extreme pressure). Additional 36 items in five problem areas - practical family, emotional, spiritual, physical, are rated for distress and a score of 5 or higher is considered significant stress.

    Measured: 2-6 weeks pre-surgery, 6 weeks post-surgery

  5. Change in Psychological Stress- Impact of Events Scale

    This is a self-report measure of traumatic stress symptoms focused on intrusive thoughts and avoidant behaviours. Questions will be adapted to reflect the PM diagnosis specifically. Frequency of symptoms will be self-reported during the previous week using a 4 point scale from 0 (not at all) to 5 (often). Total scores range from 0 to 75 with higher scores indicative of greater cancer-related stress. Scores in the range of > 30 are reflective of clinically significant stress. Higher scores on an adapted IES are related to decreased immune function in breast cancer patients.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  6. Change in Cognitive Reserve-Cognitive Reserve Index (CR-IQ)

    This questionnaire is a semi-structured interview with the patients that measures reserve in three parts: Education; Working-Activity, and Leisure time. Each sub-scale and total index score is correlated with age and expressed on a standardised scale.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  7. Change in Cognition- FACT-Cog

    The Functional Assessment of Cancer Therapy- Cognition is a self-report 37 item questionnaire that assesses cancer related cognitive problems. Sub-scales include: Perceived cognitive impairments, impact of perceived cognitive impairments on QoL, Comments from others and perceived cognitive abilities.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  8. Change in Self-Efficacy

    This is a 12 item Communication and Attitudinal Self-Efficacy scale for Cancer, and rates a patients' perceived ability to seek information, understand and engage in care, and maintain a positive attitude. Confidence level for each skill is rated on a 4 point scale with higher score indicative of higher self-efficacy.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  9. Change in Health Related Quality of Life (HrQoL)-EQ-5D-5L (5L)

    This is a standardised and validated self-report measure describing health status. It is disease non-specific but applicable to cancer, with five dimensions (mobility, self-care, typical activities, pain, anxiety/depression) with three problem levels to rate (some to extremely problematic). The higher the index score, the higher the perceived health status.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  10. Change in Health Related Quality of Life (HrQoL)- FACT-G

    This is a version of the Functional Assessment of Cancer Therapy is a 28-item self-report survey that measures quality of life; it has 5 sub-scales measures physical well-being (PWB), functional wellbeing (FWB), social/family wellbeing (SFWB), emotional wellbeing (EWB) and satisfaction with care. Self-ratings of all 5 subscales for the present moment and the preceding week are captured, computing an overall total score. Good Cronbach's for all five have been reported, and the higher the core the better the QoL.

    Measured: 2-6 weeks surgery, 6 weeks post surgery

  11. Change in Nutritional Status-The Malnutrition Screening Tool

    The Malnutrition Screening Tool (MST) is an easy to administer tool. It is based on recent appetite and weight loss and has been previously validated for use with oncology patients. The measure scores both "recent intake" and "recent weight loss". A total score of >2 indicates a risk of malnutrition.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  12. Change in Nutritional Status- Glasgow Prognostic Score

    This measure of cancer prognosis is measured using serum markers CRP and Albumin. The score is used to measure the cancer prognosis. The score ranges from 0-2, with patients with a normal measure of CRP assigned a score of zero, and those with both elevated or reduced levels a score of 2.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  13. Change in Dietary Intake - Foodbook24

    Foodbook24 is a Web-based, dietary tool consisting of a 24-hour dietary recall and food frequency questionnaire. Patients will provide dietary recall information about what they have eaten in the past 24 hours.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

  14. Change in Nutritional Status- Blood Screening

    Bloods should be ordered by clinician for Iron (Fe) analysis (identify anaemia) and CT scans of patients should be analysed for the identification of incidence of sarcopenia.

    Measured: 2-6 weeks pre-surgery, 6 weeks post surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2022
  2. Study start1 Sep 2022
  3. Primary completion1 Jun 2024 (estimated)
  4. Study completion1 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel group randomised 1:1 controlled multi-centre trial
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05305820
Sponsor's protocol ID
COALESE/2021/103
Other IDs
COALESE/2021/103
Acronym
PANO
Status last verified
Mar 2024
First submitted
15 Feb 2022
Last updated
21 Mar 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and Nutrition in people with Peritoneal Malignancy and Ovarian Cancer, run by Dublin City University at 3 sites in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of Adherence to the Intervention (time frame: 2-6 weeks pre surgery, 6 weeks post-surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in